☆ 4.5 Article

Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Related references

Note: Only part of the references are listed.

Review Cardiac & Cardiovascular Systems

Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases

Mariann Gyongyosi et al.

Summary: Long COVID is a global non-communicable epidemic characterized by long-lasting multiorgan symptoms after SARS-CoV-2 infection has subsided. This scientific document aims to provide insight into the cardiovascular manifestations of long COVID and the possible causes and therapeutic options available. Imaging has shown evidence of chronic perimyocarditis, arterial wall inflammation, and microthrombosis in certain patient populations. Understanding the underlying cellular and molecular mechanisms is crucial for the development of effective treatment strategies. However, current biomarkers are not highly predictive for the presence or outcome of long COVID.

CARDIOVASCULAR RESEARCH (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19

Sean M. Davidson et al.

Summary: COVID-19, caused by SARS-CoV-2, can lead to a dysregulated inflammatory response known as a cytokine storm. Suppressing these cytokine elevations may improve outcomes. Remote ischemic conditioning (RIC) is a simple procedure being tested in a pilot clinical trial to see if it can suppress the production of inflammatory cytokines in COVID-19 patients.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

Add to Collection

Editorial Material Multidisciplinary Sciences

Th1/Th2/Th17 Cytokine Profile among Different Stages of COVID-19 Infection

Gaurav Gupta et al.

Summary: This study aimed to characterize the cytokine profile of Th1/Th2/Th17 among different stages of COVID-19 infection. The results showed dynamic expression of these cytokines in COVID-19 patients, with IL-6 being the only statistically significant one.

NATIONAL ACADEMY SCIENCE LETTERS-INDIA (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Remote ischaemic conditioning: defining critical criteria for success-report from the 11th Hatter Cardiovascular Workshop

R. M. Bell et al.

Summary: The Hatter Cardiovascular Institute biennial workshop focused on the future of Remote Ischaemic Conditioning (RIC), discussing the mechanisms of conditioning, the disconnect between preclinical and clinical studies, and the potential applications of RIC in other diseases. The workshop proposed specific classifications to identify responders and non-responders.

BASIC RESEARCH IN CARDIOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama et al.

Summary: Among hospitalized patients with Covid-19 pneumonia not on mechanical ventilation, tocilizumab reduced the risk of progression to mechanical ventilation or death, but did not improve overall survival. There were no new safety concerns identified.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It

Stefano Cappanera et al.

Summary: The study proposed a Cytokine Storm Score (CSs) to identify COVID-19 patients in a hyperinflammation stage, enabling timely treatment to reduce mortality.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Immunology

The Importance of Understanding the Stages of COVID-19 in Treatment and Trials

Daniel O. Griffin et al.

AIDS REVIEWS (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response

Lucie Pearce et al.

Summary: The anti-inflammatory effects of remote ischaemic conditioning (RIC) may be beneficial for cardiac protection, especially during the COVID-19 pandemic. Studies show that RIC attenuates inflammation in animals through immune conditioning and cytokine inhibition, suggesting that RIC may exert its effects by inhibiting the release of inflammatory cytokines.

BASIC RESEARCH IN CARDIOLOGY (2021)

Add to Collection

Article Immunology

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia

Andre Santa Cruz et al.

Summary: Hyper-inflammatory responses induced by SARS-CoV-2 are major factors in disease severity and death, with IL-6 levels showing a significant correlation with disease stages and outcomes in COVID-19 patients, particularly in relation to respiratory failure. IL-6 also outperforms CRP as a predictive marker for disease progression.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Immunology

The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?

Dounia Darif et al.

Summary: This article summarizes the pathogenesis of cytokine release syndrome (CRS) in patients with COVID-19, the potential causes of inflammatory responses, and the clinical outcomes of this phenomenon in severe cases.

MICROBIAL PATHOGENESIS (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention

Zunyou Wu et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Article Medicine, Research & Experimental

Clinical and immunological features of severe and moderate coronavirus disease 2019

Guang Chen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Review Pharmacology & Pharmacy

The cytokine storm of COVID-19: a spotlight on prevention and protection

Lucie Pearce et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2020)

Add to Collection

Article Allergy

IL-6-based mortality risk model for hospitalized patients with COVID-19

Rocio Laguna-Goya et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Review Infectious Diseases

The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19

Qing Ye et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Add to Collection

News Item Biotechnology & Applied Microbiology

Focus shifts to antibody cocktails for COVID-19 cytokine storm

Charlotte Harrison

NATURE BIOTECHNOLOGY (2020)

Add to Collection

Article Surgery

Diagnosis and treatment of coronavirus disease 2019 (COVID-19): Laboratory, PCR, and chest CT imaging findings

Ebrahim Abbasi-Oshaghi et al.

INTERNATIONAL JOURNAL OF SURGERY (2020)

Add to Collection

Review Medicine, Research & Experimental

The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

Hamed Akbari et al.

LIFE SCIENCES (2020)

Add to Collection

Article Virology

IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection

Ana Carolina Gadotti et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Immunology

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Miriam Merad et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Add to Collection

Review Respiratory System

TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis

Xue-Yan Chen et al.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)

Add to Collection

Article Rheumatology

COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study

Jessica J. Manson et al.

LANCET RHEUMATOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Acute and chronic remote ischemic conditioning attenuate septic cardiomyopathy, improve cardiac output, protect systemic organs, and improve mortality in a lipopolysaccharide-induced sepsis model

Takashi Honda et al.

BASIC RESEARCH IN CARDIOLOGY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI)

Antonio Gaspar et al.

BASIC RESEARCH IN CARDIOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

The SAFE pathway for cardioprotection: is this a promising target?

Nkanyiso Hadebe et al.

BASIC RESEARCH IN CARDIOLOGY (2018)

Add to Collection

Article Surgery

Survival benefits of remote ischemic conditioning in sepsis

Bellal Joseph et al.

JOURNAL OF SURGICAL RESEARCH (2017)

Add to Collection

Article Medicine, General & Internal

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Review Cardiac & Cardiovascular Systems

Ischaemic conditioning and reperfusion injury

Derek J. Hausenloy et al.

NATURE REVIEWS CARDIOLOGY (2016)

Add to Collection

Letter Cardiac & Cardiovascular Systems

Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis

Derek M. Yellon et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

Remote Ischemic Conditioning

Gerd Heusch et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Add to Collection

Article Immunology

Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model

Yun-Hee Kim et al.

JOURNAL OF INFLAMMATION-LONDON (2014)

Add to Collection

Review Cardiac & Cardiovascular Systems

Myocardial Conditioning: Opportunities for Clinical Translation

Michel Ovize et al.

CIRCULATION RESEARCH (2013)

Add to Collection

Article Medicine, General & Internal

Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease

Ole Haagen Nielsen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Review Cardiac & Cardiovascular Systems

Postconditioning: From the Bench to Bedside

Martin Cour et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2011)

Add to Collection

Review Cardiac & Cardiovascular Systems

The therapeutic potential of ischemic conditioning: an update

Derek J. Hausenloy et al.

NATURE REVIEWS CARDIOLOGY (2011)

Add to Collection

Article Computer Science, Interdisciplinary Applications

Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support

Paul A. Harris et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2009)

Add to Collection

Article Dermatology

Tumor necrosis factor and tuberculosis

Philana Ling Lin et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2007)

Add to Collection

Review Biochemistry & Molecular Biology

The virus battles:: IFN induction of the antiviral state and mechanisms of viral evasion

DE Levy et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.